These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 24306676)

  • 1. A case study of in silico modelling of ciprofloxacin hydrochloride/metallic compound interactions.
    Stojkovic A; Parojcic J; Djuric Z; Corrigan OI
    AAPS PharmSciTech; 2014 Apr; 15(2):270-8. PubMed ID: 24306676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biopharmaceutical characterisation of ciprofloxacin-metallic ion interactions: comparative study into the effect of aluminium, calcium, zinc and iron on drug solubility and dissolution.
    Stojković A; Tajber L; Paluch KJ; Djurić Z; Parojčić J; Corrigan OI
    Acta Pharm; 2014 Mar; 64(1):77-88. PubMed ID: 24670353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An in silico approach to determine challenges in the bioavailability of ciprofloxacin, a poorly soluble weak base with borderline solubility and permeability characteristics.
    Hansmann S; Miyaji Y; Dressman J
    Eur J Pharm Biopharm; 2018 Jan; 122():186-196. PubMed ID: 29111469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
    Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
    Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biopharmaceutical characterization of ciprofloxacin HCl-ferrous sulfate interaction.
    Parojčić J; Stojković A; Tajber L; Grbić S; Paluch KJ; Djurić Z; Corrigan OI
    J Pharm Sci; 2011 Dec; 100(12):5174-84. PubMed ID: 21789771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In Silico Modeling of Gastrointestinal Drug Absorption: Predictive Performance of Three Physiologically Based Absorption Models.
    Sjögren E; Thörn H; Tannergren C
    Mol Pharm; 2016 Jun; 13(6):1763-78. PubMed ID: 26926043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A strategy for preclinical formulation development using GastroPlus as pharmacokinetic simulation tool and a statistical screening design applied to a dog study.
    Kuentz M; Nick S; Parrott N; Röthlisberger D
    Eur J Pharm Sci; 2006 Jan; 27(1):91-9. PubMed ID: 16219449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Food effect: The combined effect of media pH and viscosity on the gastrointestinal absorption of ciprofloxacin tablet.
    Radwan A; Zaid AN; Jaradat N; Odeh Y
    Eur J Pharm Sci; 2017 Apr; 101():100-106. PubMed ID: 28163162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting pharmacokinetic food effects using biorelevant solubility media and physiologically based modelling.
    Jones HM; Parrott N; Ohlenbusch G; Lavé T
    Clin Pharmacokinet; 2006; 45(12):1213-26. PubMed ID: 17112297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of a generic physiologically based pharmacokinetic model for lineshape analysis.
    Peters SA
    Clin Pharmacokinet; 2008; 47(4):261-75. PubMed ID: 18336055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction Characteristics of Oral Absorption Simulation Software Evaluated Using Structurally Diverse Low-Solubility Drugs.
    Matsumura N; Hayashi S; Akiyama Y; Ono A; Funaki S; Tamura N; Kimoto T; Jiko M; Haruna Y; Sarashina A; Ishida M; Nishiyama K; Fushimi M; Kojima Y; Yoneda K; Nakanishi M; Kim S; Fujita T; Sugano K
    J Pharm Sci; 2020 Mar; 109(3):1403-1416. PubMed ID: 31863733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biowaiver monographs for immediate release solid oral dosage forms: ciprofloxacin hydrochloride.
    Olivera ME; Manzo RH; Junginger HE; Midha KK; Shah VP; Stavchansky S; Dressman JB; Barends DM
    J Pharm Sci; 2011 Jan; 100(1):22-33. PubMed ID: 20602455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of Modeling and Simulation Tools for Understanding the Impact of Formulation on the Absorption of a Low Solubility Compound: Ciprofloxacin.
    Martinez M; Mistry B; Lukacova V; Polli J; Hoag S; Dowling T; Kona R; Fahmy R
    AAPS J; 2016 Jul; 18(4):886-97. PubMed ID: 27116024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the GastroPlus™ Advanced Compartmental and Transit (ACAT) Model in Early Discovery.
    Gobeau N; Stringer R; De Buck S; Tuntland T; Faller B
    Pharm Res; 2016 Sep; 33(9):2126-39. PubMed ID: 27278908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of pH dependent absorption using in vitro, in silico, and in vivo rat models: Early liability assessment during lead optimization.
    Saxena A; Shah D; Padmanabhan S; Gautam SS; Chowan GS; Mandlekar S; Desikan S
    Eur J Pharm Sci; 2015 Aug; 76():173-80. PubMed ID: 25960252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of ARA/PPI Drug-Drug Interactions at the Drug Discovery and Development Interface.
    Dodd S; Kollipara S; Sanchez-Felix M; Kim H; Meng Q; Beato S; Heimbach T
    J Pharm Sci; 2019 Jan; 108(1):87-101. PubMed ID: 30385285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IMI - Oral biopharmaceutics tools project - Evaluation of bottom-up PBPK prediction success part 4: Prediction accuracy and software comparisons with improved data and modelling strategies.
    Ahmad A; Pepin X; Aarons L; Wang Y; Darwich AS; Wood JM; Tannergren C; Karlsson E; Patterson C; Thörn H; Ruston L; Mattinson A; Carlert S; Berg S; Murphy D; Engman H; Laru J; Barker R; Flanagan T; Abrahamsson B; Budhdeo S; Franek F; Moir A; Hanisch G; Pathak SM; Turner D; Jamei M; Brown J; Good D; Vaidhyanathan S; Jackson C; Nicolas O; Beilles S; Nguefack JF; Louit G; Henrion L; Ollier C; Boulu L; Xu C; Heimbach T; Ren X; Lin W; Nguyen-Trung AT; Zhang J; He H; Wu F; Bolger MB; Mullin JM; van Osdol B; Szeto K; Korjamo T; Pappinen S; Tuunainen J; Zhu W; Xia B; Daublain P; Wong S; Varma MVS; Modi S; Schäfer KJ; Schmid K; Lloyd R; Patel A; Tistaert C; Bevernage J; Nguyen MA; Lindley D; Carr R; Rostami-Hodjegan A
    Eur J Pharm Biopharm; 2020 Nov; 156():50-63. PubMed ID: 32805361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Forecasting in vivo oral absorption and food effect of micronized and nanosized aprepitant formulations in humans.
    Shono Y; Jantratid E; Kesisoglou F; Reppas C; Dressman JB
    Eur J Pharm Biopharm; 2010 Sep; 76(1):95-104. PubMed ID: 20576487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving Dissolution Behavior and Oral Absorption of Drugs with pH-Dependent Solubility Using pH Modifiers: A Physiologically Realistic Mass Transport Analysis.
    Salehi N; Kuminek G; Al-Gousous J; Sperry DC; Greenwood DE; Waltz NM; Amidon GL; Ziff RM; Amidon GE
    Mol Pharm; 2021 Sep; 18(9):3326-3341. PubMed ID: 34428047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In Vitro-In Vivo Correlation Using In Silico Modeling of Physiological Properties, Metabolites, and Intestinal Metabolism.
    Choi SM; Kang CY; Lee BJ; Park JB
    Curr Drug Metab; 2017; 18(11):973-982. PubMed ID: 29086683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.